Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

MEDRELEAF CORP T.LEAF

Healthcare Drug Manufacturers - Specialty & Generic
"MedReleaf Corp is engaged in the production and sale of cannabis for medical purposes as regulated by the ACMPR, pursuant to its Licences and, in particular, its Markham Commercial Licence."


TSX:LEAF - Post by User

MEDRELEAF CORP > Morningstar Quant Rept. Values LEAF at $31.60
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(40)
•••
Comment by BirchBrookon May 04, 2018 3:19pm
66 Views
Post# 27984783

RE:RE:RE:RE:RE:Morningstar Quant Rept. Values LEAF at $31.60

RE:RE:RE:RE:RE:Morningstar Quant Rept. Values LEAF at $31.60Leaf only has 23,000 sq/ft of growing space to date. Gonna need great deal of dillution to finish what they started. No wonder they are looking to sell.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities